OTHER · Unmapped registry intervention
Portal Message with Reminder Text Messages
Find medicine records ·
Find other trials using this name
Clinical trial
A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients
NCT07322367
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Text Message with Reminder Text Messages
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Portal message only
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Usual Care
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients
Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
Sponsors & collaborators
Wake Forest University Health Scienceslead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07322367 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.